Latest episodes of the podcast OncTimes Talk
Mostrando página 4 de 5
Study Supports Osimertinib as Standard of Care for Patients With Locally Advanced EGFR-Mutated NSCLC
11/06/2024
Bispecific T-cell Engager Antibody Brings Deep, Durable Remissions in R/R Multiple Myeloma
02/05/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.